Study to Determine the Effect of Azasite on Corneal Surface Irregularity
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Transplantation and the Use of Raltegravir in HIV-Infected Patients
- Status
- COMPLETED
- Phase
- N/A
Improving Pneumococcal Vaccination Rates in an Ambulatory Pre-surgical Testing Setting
- Status
- COMPLETED
- Phase
- NA
A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069)
- Status
- COMPLETED
- Phase
- PHASE3
Pharmacokinetic Drug Interaction Study Between Raltegravir and Atorvastatin.
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetics and Safety of Posaconazole Tablet in Participants at High Risk for Invasive Fungal Infections (MK-5592-065/P05615)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Viral Response to Triple Therapy in Hepatitis C Virus-Infected Participants With Insulin Resistance Who Failed Dual Therapy (MK-3034-113)
- Status
- WITHDRAWN
- Phase
- PHASE4
Raltegravir (Isentress) Pilot Study in Relapsing Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2
A Pharmacokinetic Study of MK-3102 in Participants With Impaired Hepatic Function (MK-3102-031)
- Status
- COMPLETED
- Phase
- PHASE1
An Observational Modified Prescription-event Monitoring Study of Asenapine (Sycrest)
- Status
- COMPLETED
- Phase
- N/A
A Multicenter, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Sorafenib in First-line Treatment of Participants With Unresectable Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3
A Study of the Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy in Japanese Participants With Dyslipidemia (MK-0859-051 AM1)
- Status
- COMPLETED
- Phase
- PHASE3
A Pooled Analysis of the Safety and Efficacy of MK-0431A and MK-0431A XR in Pediatric Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Therapy (Alone or in Combination With Insulin) (MK-0431A-170/MK-0431A-289)
- Status
- COMPLETED
- Phase
- PHASE3
Pegylated Interferon Alpha-2b in Early Primary Myelofibrosis
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Evaluate the Efficacy and Safety of Boceprevir Added to Standard of Care Therapy in Previously Treated Participants With Chronic Hepatitis C Genotype 1 and Cirrhosis (MK-3034-105)
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Evaluate the Safety, Tolerability, and Efficacy of the Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Therapy (MK-3102-024)
- Status
- COMPLETED
- Phase
- PHASE3
CURES: The Effect of Deep Curarisation and Reversal With Sugammadex on Surgical Conditions and Perioperative Morbidity
- Status
- COMPLETED
- Phase
- PHASE4
Addition of Vorinostat to Azacitidine in Higher Risk MDS a Phase II add-on Study in Patients With Azacitidine Failure
- Status
- TERMINATED
- Phase
- PHASE2
Partnership for Applied Research in Fracture Prevention Programs for the Elderly
- Status
- UNKNOWN
- Phase
- NA
Study to Determine if Gardasil Vaccine is Safe and Effective in Lupus Patients
- Status
- COMPLETED
- Phase
- PHASE1